De Strooper; Bart

Patent Applications and Registrations

Patent applications and USPTO patent grants for De Strooper; Bart.The latest application filed is for "gamma-secretase stabilizing compound screening assay".

Company Profile

2.14.16

De Strooper; Bart - Leuven BE
De Strooper; Bart - Hoeilaart BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
.GAMMA.-secretase stabilizing compound screening assay Grant 11,346,848 - De Strooper , et al. May 31, 2	2022-05-31
Therapeutic agents for neurological and psychiatric disorders Grant 10,829,528 - De Wit , et al. November 10, 2	2020-11-10
Gamma-secretase Stabilizing Compound Screening Assay App 20190339292 - DE STROOPER; Bart ; et al.	2019-11-07
Single domain antibodies capable of modulating BACE activity Grant 10,377,834 - De Strooper , et al. A	2019-08-13
Therapeutic Agents for Neurological and Psychiatric Disorders App 20190225662 - DE WIT; Joris ; et al.	2019-07-25
Single Domain Antibodies Capable Of Modulating Bace Activity App 20180230232 - De Strooper; Bart ; et al.	2018-08-16
Single domain antibodies capable of modulating BACE activity Grant 9,908,943 - De Strooper , et al. March 6, 2	2018-03-06
Restoring phosphorylation of a novel PINK1 substrate to treat parkinson's disease Grant 9,879,233 - De Strooper , et al. January 30, 2	2018-01-30
Single Domain Antibodies Capable Of Modulating Bace Activity App 20160237166 - De Strooper; Bart ; et al.	2016-08-18
Means And Method For Diagnosis And Treatment Of Alzheimer's Disease App 20150301068 - DE STROOPER; Bart ; et al.	2015-10-22
Restoring Phosphorylation Of A Novel Pink1 Substrate To Treat Parkinson's Disease App 20150299672 - DE STROOPER; Bart ; et al.	2015-10-22
Single Domain Antibodies Capable Of Modulating Bace Activity App 20150071940 - De Strooper; Bart ; et al.	2015-03-12
BACE1 inhibitory antibodies Grant 8,956,614 - De Strooper , et al. February 17, 2	2015-02-17
Screening methods for compounds that modulate ARF-6 mediated endosomal redistribution Grant 8,790,887 - Annaert , et al. July 29, 2	2014-07-29
Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation Grant 8,580,493 - De Strooper , et al. November 12, 2	2013-11-12
Single domain antibodies capable of modulating BACE activity Grant 8,568,717 - De Strooper , et al. October 29, 2	2013-10-29
Arf6 As A New Target For Treating Alzheimer's Disease App 20120276076 - Annaert; Wim ; et al.	2012-11-01
Bace1 Inhibitory Antibodies App 20120237526 - De Strooper; Bart ; et al.	2012-09-20
Screening For Compounds That Modulate Gpr3-mediated Beta-arrestin Signaling And Amyloid Beta Peptide Generation App 20120136045 - De Strooper; Bart ; et al.	2012-05-31
Single Domain Antibodies Capable Of Modulating Bace Activity App 20110091446 - De Strooper; Bart ; et al.	2011-04-21
Extracellular Targets For Alzheimer's Disease App 20110008350 - De Strooper; Bart ; et al.	2011-01-13
Oligonucleotide Compositions For The Treatment Of Alzheimer's Disease App 20100204309 - Herbert; Sebastien ; et al.	2010-08-12
Transgenic Animal Models for Neurodevelopmental Disorders App 20080120731 - De Strooper; Bart ; et al.	2008-05-22
Binding domains between presenilins and their substrates as targets for drug screening Grant 7,198,903 - De Strooper , et al. April 3, 2	2007-04-03
Non-human animal disease models App 20040093623 - Debyser, Zeger ; et al.	2004-05-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.